Zoetis Inc (NYSE:ZTS)

127.64
Delayed Data
As of Aug 21
 +1.59 / +1.26%
Today’s Change
78.90
Today|||52-Week Range
128.41
+49.22%
Year-to-Date
Bayer Sells Animal Health Division to Elanco: Now What?
Aug 20 / Zacks.com - Paid Partner Content
Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates
Aug 09 / Zacks.com - Paid Partner Content
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
Aug 14 / Zacks.com - Paid Partner Content
Has Zoetis (ZTS) Outpaced Other Medical Stocks This Year?
Aug 09 / Zacks.com - Paid Partner Content
HKMPF or ZTS: Which Is the Better Value Stock Right Now?
Aug 14 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run?
Aug 09 / Zacks.com - Paid Partner Content
3 Healthcare Stocks at All-Time Highs: Are They Buys?
Aug 14 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close126.05
Today’s open126.84
Day’s range126.20 - 128.13
Volume1,874,969
Average volume (3 months)1,980,378
Market cap$59.9B
Data as of 6:30pm ET, 08/21/2019

Growth & Valuation

Earnings growth (last year)+67.96%
Earnings growth (this year)+13.77%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)+9.76%
P/E ratio45.1
Price/Sales7.15
Price/Book27.51

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+0.42+0.44%
AGNAllergan+2.14+1.34%
TAKTakeda Pharmaceutica...-0.26-1.55%
VRTXVertex Pharmaceutica...+2.68+1.46%
Data as of 6:30pm ET, 08/21/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)$0.88
Annual revenue (last year)$5.8B
Annual profit (last year)$1.4B
Net profit margin24.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Juan Ramón Alaix
Chief Financial Officer &
Executive Vice President
Glenn C. David
Corporate headquarters
Parsippany, New Jersey

Forecasts